MeSH Browser

MeSH Heading: Sympatholytics
Tree Number(s): D27.505.696.663.050.850
Unique ID: D013565
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D013565
Annotation: note entry term SYMPATHOLYTIC EFFECT: use only for the sympatholytic effect of a chemical substance
Scope Note: Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
Entry Term(s): Sympathetic-Blocking Agents; Sympatholytic; Sympatholytic Agent; Sympatholytic Agents; Sympatholytic Drug; Sympatholytic Drugs; Sympatholytic Effect; Sympatholytic Effects
NLM Classification #: QV 132
See Also: Adrenergic Agents; Adrenergic Antagonists
Public MeSH Note: ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Online Note: use SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81
History Note: ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Date Established: 1960/01/01
Date of Entry: 1999/01/01
Revision Date: 2021/06/30

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0020945
Scope Note: Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
Terms: Sympatholytics Preferred Term
Term UI T039891
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1966); Sympatholytic Agent
Term UI T001090461
Date10/23/2020
LexicalTag NON
ThesaurusID NLM (2022); Sympatholytic
Term UI T001090462
Date10/23/2020
LexicalTag NON
ThesaurusID NLM (2022); Sympatholytic Drug
Term UI T001090460
Date10/23/2020
LexicalTag NON
ThesaurusID NLM (2022); Sympathetic-Blocking Agents
Term UI T039890
Date04/21/1977
LexicalTag NON
ThesaurusID UNK (19XX); Sympatholytic Agents
Term UI T039892
Date04/06/1994
LexicalTag NON
ThesaurusID NLM (1995); Sympatholytic Drugs
Term UI T039893
Date04/06/1994
LexicalTag NON
ThesaurusID NLM (1995)

Sympatholytics MeSH Descriptor Data 2024